A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy with or without Pembrolizumab (MK-3475) in Adults with First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)

Trial Identifier: 3475-407
Sponsor: MSD
Start Date: June 2016
Primary Completion Date: April 2018
Study Completion Date: September 2023
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary - French (France)
Results Plain Language Summary - EMEA Polish
Results Plain Language Summary - EMEA Hungarian
Results Plain Language Summary - NA French Canadian
Results Plain Language Summary - EMEA Dutch
Results Plain Language Summary – English
Results Plain Language Summary - EMEA Russian
Results Plain Language Summary - EMEA German
Results Plain Language Summary - LA Spanish
Results Plain Language Summary - EMEA Italian

Trial Locations

No locations posted.